Clinical Trial

The Treatment of Liver Injury After Liver Resection With Polyene Phosphatidylcholine

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
A multicenter, open-label, randomized, controlled study. It is proposed to evaluate the treatment plan of receiving 930mg polyene phosphatidylcholine injection one day before the operation, twice a day, and 930mg polyene phosphatidylcholine injection twice a day,combined with 100mg of magnesium isoglycyrrhizinate injection once a day,from the 1st to the 5th day after the operation. Compared with the monotherapy regimen of no liver protection treatment before the operation and receiving magnesium isoglycyrrhizinate injection 100mg once a day from the 1st to the 5th day after the operation.The efficacy and safety of treating postoperative liver function injury in patients undergoing laparoscopic hepatectomy for hepatocellular carcinoma were compared.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-08-28.
Trial Details
NCT Number NCT07150624
Lead Sponsor Anhui Provincial Hospital
Collaborators: The First Affiliated Hospital of Anhui Medical University, The Second Hospital of Anhui Medical University, The First Affiliated Hospital of Bengbu Medical University, First Affiliated Hospital of Wannan Medical College
Conditions Hepatocellular Carcinoma (HCC), Liver Diseases
Enrollment 96 participants
Start Date 2025-11-10
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-11